FPHAX holdings — Select Pharmaceuticals Portfolio
Select Pharmaceuticals Portfolio (FPHAX) held 57 positions with net assets of $1.50B as of May 31, 2026, according to its Form N-PORT report to the SEC. Its top 10 holdings make up 73.8% of the fund, led by LLY, GSK, VTRS.
FPHAX top holdings
- LLY ELI LILLY and CO — 28.78% ($432M)
- GSK GSK PLC — 8.17% ($123M)
- VTRS VIATRIS INC — 5.45% ($81.8M)
- UCB SA — 5.09% ($76.4M)
- MRK MERCK and CO INC — 4.74% ($71.2M)
- ROCHE HOLDING AG — 4.54% ($68.2M)
- LEGN LEGEND BIOTECH CORP — 4.53% ($68.0M)
- ASTRAZENECA PLC — 4.22% ($63.4M)
- ELAN ELANCO ANIMAL HEALTH INC — 4.15% ($62.3M)
- JAZZ PHARMACEUTICALS PLC — 4.09% ($61.4M)
- GILD GILEAD SCIENCES INC — 3.97% ($59.5M)
- JNJ JOHNSON and JOHNSON — 3.77% ($56.6M)
- ROYALTY PHARMA PLC — 2.67% ($40.1M)
- Fidelity Revere Street Trust — 2.44% ($36.7M)
- MRNA MODERNA INC — 1.57% ($23.6M)
- NTLA INTELLIA THERAPEUTICS INC — 1.19% ($17.8M)
- BEAM BEAM THERAPEUTICS INC — 1.10% ($16.5M)
- AXSM AXSOME THERAPEUTICS INC — 1.08% ($16.2M)
- BNTX BIONTECH SE — 1.04% ($15.7M)
- XENE XENON PHARMACEUTICALS INC — 0.82% ($12.4M)
- OCUL OCULAR THERAPEUTIX INC — 0.80% ($12.0M)
- IDXX IDEXX LABORATORIES INC — 0.61% ($9.13M)
- SWEDISH ORPHAN BIOVITRUM AB — 0.54% ($8.15M)
- PTCT PTC THERAPEUTICS INC — 0.54% ($8.12M)
- CAPR CAPRICOR THERAPEUTICS INC — 0.46% ($6.93M)
What are FPHAX's top 10 holdings?
LLY (28.8%), GSK (8.2%), VTRS (5.5%), UCB SA (5.1%), MRK (4.7%), ROCHE HOLDING AG (4.5%), LEGN (4.5%), ASTRAZENECA PLC (4.2%), ELAN (4.1%), JAZZ PHARMACEUTICALS PLC (4.1%).
How many stocks are in FPHAX?
Select Pharmaceuticals Portfolio reported 57 holdings as of May 31, 2026.